Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Vishay Intertechnology Inc. Common Stock (VSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Vishay Intertechnology Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $111.12 (market cap $12.58B), while Vishay Intertechnology Inc. Common Stock trades at $34.14 (market cap $5.30B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.4× Vishay Intertechnology Inc. Common Stock's market cap, and Vishay Intertechnology Inc. Common Stock pays a 1.16% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Vishay Intertechnology Inc. Common Stock for 1 Days on average.
| HALO | VSH | |
|---|---|---|
Market Cap | $12.58B | $5.30B |
Volume | 2,179,278 | 3,213,272 |
Sector | Health | Technology |
52-Week High | $115.22 | $64.90 |
52-Week Low | $61.63 | $11.82 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $5.10B |
Dividend Yield | — | 1.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Vishay Intertechnology Inc. Common Stock
Vishay Intertechnology manufactures discrete semiconductors and passive electronic components. Its products include diodes, MOSFETs, resistors, capacitors, and sensors.
Read more on VSH →
